Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform
In this session, William Lian from BioDuro covers the current FDA IND landscape: where IND submission changes, how Clinical Holds get resolved, and why getting CMC right early is the key to avoiding them.
